EXHIBIT 107
Calculation of Filing Fee Table
Form S-8
Pacific Biosciences of California, Inc.
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered (1) | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee |
Equity | Common stock, $0.001 par value per share | Other | 18,000,000 (2) | $5.47 (3) | $98,460,000 | $0.0000927 | $9,127.25 |
Total Offering Amounts | $98,460,000 | $9,127.25 | |||||
Total Fee Offsets | |||||||
Net Fee Due | $9,127.25 |
(1) | Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that become issuable under the 2020 Equity Incentive Plan (“2020 Plan”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without receipt of consideration that increases the number of the Registrant’s outstanding shares of common stock. |
(2) | Represents 18,000,000 shares of common stock reserved for issuance pursuant to awards under the 2020 Plan. |
(3) | Estimated in accordance with Rule 457(c) and Rule 457(h) of the Securities Act solely for purposes of calculating the registration fee on the basis of $5.47, the average of the high and low prices of Registrant’s common stock as reported on the NASDAQ Global Select Market on May 25, 2022. |